O'Shaughnessy Asset Management, LLC Cti Biopharma Corp Transaction History

O'Shaughnessy Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.44 - $2.86 $462 - $918	-321 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$2.25 - $3.18 $191 - $270	-85 Reduced 20.94%	321 $1,000
Q1 2021 May 14, 2021	SELL	$2.68 - $3.8 $632 - $896	-236 Reduced 36.76%	406 $1,000
Q4 2020 Feb 11, 2021	BUY	$2.48 - $3.8 $1,254 - $1,922	506 Added 372.06%	642 $2,000
Q2 2020 Aug 13, 2020	BUY	$0.88 - $1.32 $119 - $179	136 New	136 $0

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.